tiprankstipranks
Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market

Entero Therapeutics (ENTO) Ownership - Who Owns Entero Therapeutics?

1,209 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 03, 2024
James Sapirstein
Chairman & Ceo,director
xxxxxxxxxxxxx
$1379
Jul 03, 2024
xxxxxxxxxxxxx
$664
Apr 03, 2024
James Sapirstein
Chairman & Ceo,director
xxxxxxxxxxxxx
$734
Apr 03, 2024
xxxxxxxxxxxxx
$317

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,535Institution0.18%4,716
4,535Institution0.18%4,716
2,852Institution0.12%2,966

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,535Institution0.18%4,716
2,852Institution0.12%2,966

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,535Institution0.18%12,245

FAQ

Who Owns Entero Therapeutics (ENTO)?
Currently, no data Available
What percentage of Entero Therapeutics (ENTO) stock is held by institutional investors?
Currently, no data Available
What percentage of Entero Therapeutics (ENTO) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Entero Therapeutics (ENTO)?
Vanguard owns the most shares of Entero Therapeutics (ENTO).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis